| |
| |
|
| Insider
Information: |
Fitzgerald Edward M |
| Relationship: |
Executive VP |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
320,367 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
320,367 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
Executive VP |
2016-03-21 |
320,367 |
2011-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2011-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,334 |
51,342 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2011-04-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,000 |
103,947 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2012-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
78,000 |
171,880 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2012-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,333 |
173,013 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2012-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,500 |
199,499 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,334 |
174,877 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,333 |
204,488 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,000 |
204,555 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,000 |
227,815 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,500 |
247,984 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,834 |
259,375 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
264,273 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,000 |
275,166 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,000 |
285,524 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
310,294 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,833 |
306,460 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
309,376 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,000 |
320,339 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
297,981 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
319,993 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
324,576 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,833 |
325,784 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-08-15 |
4 |
OE |
$3.90 |
$128,700 |
D/D |
33,000 |
247,585 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2012-04-17 |
4 |
OE |
$4.63 |
$185,200 |
D/D |
40,000 |
209,548 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2012-05-03 |
4 |
OE |
$4.63 |
$277,800 |
D/D |
60,000 |
229,548 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
